AGCO Corporation vs Regeneron Pharmaceuticals Inc — how do they compare? AGCO Corporation trades at $102.25 (market cap $7.10B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 11.6× AGCO Corporation's market cap, and AGCO Corporation pays the higher dividend (1.18%). Which is the better fit depends on your goals.
| AGCO | REGN | |
|---|---|---|
Market Cap | $7.10B | $82.06B |
Sector | Industrials | Health |
52-Week High | $140.49 | $812.27 |
52-Week Low | $100.14 | $555.51 |
Enterprise Value | $9.37B | $76.77B |
Dividend Yield | 1.18% | 0.47% |
Trailing returns across standard periods
Agco is a global manufacturer of agricultural equipment. The company has five principal brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements by offering grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes over 3,200 dealer and distribution locations. Additionally, Agco offers both retail and wholesale financing to customers through its joint venture with Rabobank, a European food and agriculture focused bank.
Read more on AGCO →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →